A significant advance in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in several kinds of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research